DNAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.895000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.538800E-01
Normal-vs-Stage2
9.146800E-01
Normal-vs-Stage3
1.724000E-01
Normal-vs-Stage4
4.424800E-01
Stage1-vs-Stage2
1.888570E-01
Stage1-vs-Stage3
1.951870E-02
Stage1-vs-Stage4
6.815000E-01
Stage2-vs-Stage3
1.547790E-01
Stage2-vs-Stage4
1.032810E-01
Stage3-vs-Stage4
1.114560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.593400E-01
Normal-vs-AfricanAmerican
8.718400E-01
Normal-vs-Asian
4.926200E-01
Caucasian-vs-AfricanAmerican
6.455000E-01
Caucasian-vs-Asian
1.689020E-01
AfricanAmerican-vs-Asian
5.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.029600E-01
Normal-vs-Female
8.663200E-01
Male-vs-Female
8.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.324800E-01
Normal-vs-Age(41-60Yrs)
5.807400E-01
Normal-vs-Age(61-80Yrs)
9.631800E-01
Normal-vs-Age(81-100Yrs)
4.736400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.651400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.796400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.495600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.601500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.663200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.455800E-01
Normal-vs-Daily Drinker
9.003400E-01
Normal-vs-Weekly Drinker
5.367400E-01
Normal-vs-Occasional Drinker
5.935200E-01
Normal-vs-Social Drinker
6.700600E-01
Non Drinker-vs-Daily Drinker
5.289400E-01
Non Drinker-vs-Weekly Drinker
9.827200E-01
Non Drinker-vs-Occasional Drinker
5.154200E-02
Non Drinker-vs-Social Drinker
1.523820E-01
Daily Drinker-vs-Weekly Drinker
5.651000E-01
Daily Drinker-vs-Occasional Drinker
1.908440E-01
Daily Drinker-vs-Social Drinker
3.017600E-01
Weekly Drinker-vs-Occasional Drinker
6.203900E-02
Weekly Drinker-vs-Social Drinker
1.618770E-01
Occasional Drinker-vs-Social Drinker
9.330200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.848200E-01
Normal-vs-Grade 2
4.278400E-02
Normal-vs-Grade 3
4.585900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.588040E-01
Grade 1-vs-Grade 3
2.494600E-01
Grade 1-vs-Grade 4
2.848200E-01
Grade 2-vs-Grade 3
4.882600E-01
Grade 2-vs-Grade 4
4.278400E-02
Grade 3-vs-Grade 4
4.585900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.448800E-01
Normal-vs-NonDiabetic
8.801200E-01
Diabetic-vs-NonDiabetic
6.644200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.741600E-01
Normal-vs-NoPancreatitis
9.219000E-01
Pancreatitis-vs-NoPancreatitis
4.157700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.740400E-01
Normal-vs-N1
9.854800E-01
N0-vs-N1
2.480800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.810200E-01
Normal-vs-TP53-NonMutant
7.194600E-01
TP53-Mutant-vs-TP53-NonMutant
2.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
